AAA. I. Afanas’eVa

A. I. Afanas’eVa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. I. Afanas’eVa has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neurofilament light chain in blood and features of the multiple sclerosis course in patients with a history of traumatic brain injury

    by A. I. Afanasyeva, E. Yu. Elchaninova, I. V. Smagina, S. A. Elchaninova

    Multiple sclerosis (MS) is a chronic disease of the central nervous system with recurrent exacerbations, leading to irreversible disability, the development of which is based on axonal damage and demyelination. It is assumed that one of the candidate biomarkers of axonal damage may be a peptide component of the neuronal cytoskeleton — neurofilament light chain (NFL). Traumatic brain injury (TBI) before the onset of MS is associated with an increased rate of progression of neurological which may be due to increased astrogliosis as a late consequence of TBI. Objective: to evaluate the relationship between the level of NFL in the blood and the RP and exacerbation frequency MS in the presence/absence of TBI before the onset of MS.Material and methods. Caucasians born and living in the Altai region of Russia with relapsing-remitting MS in remission took part in a cross-sectional observational randomized study: 43 patients without a history of TBI and 43 patients with TBI before the onset of MS (MS duration 7.6 ± 6.6 and 5.9 ± 4.6 years, respectively, p = 0,113). Intracranial injury occurred 14.8 ± 7.8 years before the onset of MS and was documented as a concussion in 76% of patients.Results. The patient groups did not differ in the frequency of MS exacerbations, while RP was higher in the group with a history of TBI (p = 0.013). There were no intergroup differences in NFL levels (p = 0.613), as well as no correlations between NFL levels and RP (p = 0.499 and p = 0.776 groups with/without TBI, respectively) and the exacerbation frequency. No differences were found between subgroups of patients with different clinical forms of TBI in RP and NFL levels (H = 5,07; p = 0,679).Conclusion. The results of the study indicate a low probability of a connection between the level of NFL in the blood of patients with MS during the period of remission, both with the possible long-term consequences of a TBI received before the onset of MS, and with the course of MS.

  • Glial fibrillary acidic protein: is there a relationship with the course of multiple sclerosis and traumatic brain injury before the onset of multiple sclerosis?

    by E.YU. Elchaninova, A.I. Afanasyeva, I.V. Smagina, S.A. Elchaninova

    Objective To evaluate the relationship between the level of glial fibrillary acidic protein (GFAP) in the blood and the rate of progression (RP) of neurological disorders and exacerbation frequency of multiple sclerosis (MS) in the presence/absence of traumatic brain injury (TBI) before the onset of MS. Material and methods. Caucasians born and living in the Altai region of Russia with relapsing-remitting MS in remission took part in a cross-sectional observational randomized study: 43 patients without a history of TBI and 43 patients with TBI before the onset of MS (mean age 36.1±9.3 and 33.5±8.2 years, MS duration 7.6±6.6 and 5.9±4.6 years, respectively). Intracranial injury occurred 14.8±7.8 years before the onset of MS and was documented as a concussion in 76% of patients. Results. The patient groups did not differ in the frequency of MS exacerbations, while RP was higher in the group with a history of TBI (p=0.013). There were no intergroup differences in GFAP levels, as well as no correlations between GFAP levels and RP (p=0.520 and p=0.255 in groups with/without TBI, respectively) and the exacerbation frequency. No differences were found between subgroups of patients with different clinical forms of TBI in RP and GFAP levels (H=0.26; p=0.880 and H=1.48; p=0.476, respectively). There was no correlation of the TBI duration with RP (p=0.902) and GFAP level (p=0.413). Conclusion. The results indicate a low probability of a connection between the level of GFAP in the blood of patients with MS during the period of remission, both with the possible long-term consequences of a TBI occurred before the onset of MS, and during the course of MS.


  • Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population

    by S.A. Sivertseva, A.M. Prilenskaya, E.V. Popova, E.L. Turova, L.I. Volkova, I.V. Smagina, E.YU. Elchaninova, A.I. Afanas’eVa, Z.A. Goncharova, E.A. Markova, et al.

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить степень тяжести и частоту возникновения инфузионных реакций (ИР) на фоне терапии препаратом алемтузумаб у пациентов с высокоактивным течением рассеянного склероза (ВАРС) в российской популяции. МАТЕРИАЛ И МЕТОДЫ В данном ретроспективном исследовании были проанализированы данные 50 пациентов с ВАРС из 6 региональных центров РС России, получивших по два курса алемтузумаба в период с 2018 по 2022 г. РЕЗУЛЬТАТЫ Из всех ИР чаще всего отмечалось появление высыпаний по типу крапивницы (n=27), преимущественно легкой степени тяжести (70,6%). На втором месте по частоте возникновения оказалась головная боль (n=17, 34%). При сравнении группы пациентов, которым проводилась музыкотерапия (МТ), и тех, кто получал алемтузумаб без МТ, статистически значимой разницы частоты и тяжести ИР не было. ЗАКЛЮЧЕНИЕ У всех пациентов были зарегистрированы ИР разной степени выраженности. Отмечалось уменьшение балла по шкале инвалидизации EDSS. МТ не оказала влияния на возникновение ИР и степень их выраженности.

  • Traumatic brain injury before the multiple sclerosis onset: a relationship with the progression of neurological disorders and pathobiochemical markers of the cerebrospinal fluid

    by E.YU. Elchaninova, A.I. Afanas’eVa, I.V. Smagina, S.A. Elchaninova

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить связь черепно-мозговой травмы (ЧМТ), полученной до дебюта рассеянного склероза (РС), со скоростью прогрессирования неврологических расстройств и маркерами проницаемости гематоэнцефалического барьера, воспаления, демиелинизации и глиоза в цереброспинальной жидкости. МАТЕРИАЛ И МЕТОДЫ В проспективном контролируемом рандомизированном исследовании приняли участие 88 больных ремиттирующим РС Алтайского края России с/без ЧМТ до дебюта РС (n=44; 19 мужчин, 25 женщин в каждой группе). Нарастание инвалидизации оценивали ретроспективно. Плеоцитоз, уровень белка, альбумина, С-реактивного белка, TNF-α, основного белка миелина, белка S100 измеряли в цереброспинальной жидкости в подгруппах пациентов (n=14 в каждой из групп) в периоды ремиссии и обострения РС. РЕЗУЛЬТАТЫ В группе больных с ЧМТ до дебюта РС документированы сотрясение и ушиб головного мозга легкой степени у 35 (79,5%) и 9 (20,5%) пациентов соответственно. У 72,5% больных ЧМТ была в возрасте старше 15 лет. Скорость прогрессирования PC была выше в группе больных с ЧМТ по сравнению с группой больных без ЧМТ (0,76±1,28 и 0,40±0,43 балла EDSS в год соответственно; p=0,014). ЧМТ до дебюта РС повышает риск нарастания инвалидизации более чем на 0,25 балла EDSS в год (ОШ 2,74; 95% ДИ 1,10—6,85; p=0,029). Ни при обострении, ни в период ремиссии РС не найдено межгрупповых различий исследованных показателей цереброспинальной жидкости. ЗАКЛЮЧЕНИЕ Сотрясение или ушиб головного мозга легкой степени тяжести до развития РС могут быть факторами, влияющими на прогрессирование неврологического дефицита. Представляется актуальным исследование механизмов неблагоприятного влияния ЧМТ на прогрессирование РС.


  • Open Access

    HLA-DRB1 polymorphism and risk of pediatric-onset and adult-onset multiple sclerosis: a case–control study

    by E. Yu. Elchaninova, I. V. Smagina, A. I. Afanas’eVa, S. A. Elchaninova

    The association of predisposition to multiple sclerosis (MS) with HLA-DRB1 gene polymorphisms is the strongest. It is not clear whether the DRB1 alleles associated with the risk of this disease diff er in adult and pediatric populations living in the same environmental conditions.Objective: comparative study of associations of HLA-DRB1 gene polymorphism with the risk of pediatric-onset MS and adult-onset MS in the Altai region.Material and methods. Caucasian with relapsing-remitting MS, born and living in the Altai region of Russia in the southeast of Western Siberia, participated in the case–control study: 200 patients with adult-onset MS, 86 patients with pediatric-onset MS. The control group included 200 volunteers. Genotyping was performed by TaqMan probes. Results. Alleles 03, 13, 15 of the HLA-DRB1 gene are genetic risk factors for both adult-onset MS and pediatric-onset MS in Caucasians in the Altai region. Alleles 01 and 07 of the HLA-DRB1 gene may have a protective eff ect against pediatric-onset MS, alleles 01, 07, 11 and 16 against adult-onset MS.Conclusion. It can be assumed that the diff erence in the age of MS onset is not associated with the diff erent infl uence of risk alleles of the HLA-DRB1 gene in populations under and over 18 years of age.